Ignite Creation Date:
2025-12-25 @ 12:11 AM
Ignite Modification Date:
2026-01-04 @ 6:56 PM
Study NCT ID:
NCT04086758
Status:
COMPLETED
Last Update Posted:
2024-11-20
First Post:
2019-09-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Sponsor:
Astellas Pharma China, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-18
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-22
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-10
First Submit QC Date:
None
Study First Post Date:
2019-09-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-18
Last Update Post Date:
2024-11-20
Last Update Post Date Type:
ACTUAL